Cellebrite DI Ltd (CLBT) Is Now En Route to Higher Prices

Cellebrite DI Ltd (NASDAQ: CLBT) is 100.92% higher on its value in year-to-date trading and has touched a low of $3.96 and a high of $8.69 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The CLBT stock was last observed hovering at around $8.36 in the last trading session, with the day’s gains setting it 0.4%.

Currently trading at $8.76, the stock is 4.53% and 13.37% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.13 million and changing 4.78% at the moment leaves the stock 26.95% off its SMA200. CLBT registered 107.58% gain for a year compared to 6-month gain of 39.05%. The firm has a 50-day simple moving average (SMA 50) of $4.83 and a 200-day simple moving average (SMA200) of $39.05.

#1 Small-Cap Uranium Stock for Ultra-Fast Gains in 2024

We've uncovered THE ONE small-cap uranium stock that has unearthed a near-surface, high-grade uranium discovery in the Saudi Arabia of Uranium — Canada's prolific Athabasca Basin. Best of all, this small-cap uranium stock is currently flying just below Wall Street's radar… giving you the early-entry opportunity around US$0.30 per share. But that won't last long. Drills are turning right now with results set to be released to the market very, very soon.

Learn all about it in this brand new FREE online report.
Sponsored

The stock witnessed a 3.06% loss in the last 1 month and extending the period to 3 months gives it a 17.43%, and is 6.31% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 3.56% over the week and 2.98% over the month.

Cellebrite DI Ltd (CLBT) has around 1005 employees, a market worth around $1.73B and $306.12M in sales. Fwd P/E is 58.60. Profit margin for the company is -19.40%. Distance from 52-week low is 121.21% and 0.81% from its 52-week high. The company has generated returns on investments over the last 12 months (-131.17%).

Cellebrite DI Ltd (CLBT) Analyst Forecasts

Analyst recommendations provided by FactSet shows that the consensus forecast for Cellebrite DI Ltd (CLBT) is a “Overweight”. 7 analysts offering their recommendations for the stock have an average rating of 1.57, where 2 rate it as a Hold and 0 think it is a “Overweight”. 5 of the analysts rate the stock as a “Buy”. 0 analysts have rated the stock as a Sell or Underperform.

Cellebrite DI Ltd is expected to release its quarterly report on 02/14/2024.The EPS is expected to shrink by -151.04% this year.

Cellebrite DI Ltd (CLBT) Top Institutional Holders

The shares outstanding are 187.68M, and float is at 50.88M with Short Float at 5.49%.

Cellebrite DI Ltd (CLBT) Insider Activity

A total of 0 insider transactions have happened at Cellebrite DI Ltd (CLBT) in the last six months, with sales accounting for 0 and purchases happening 0 times.